XML 46 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2013
STOCKHOLDERS' EQUITY  
Schedule of warrants outstanding to purchase common stock and classified as equity

As of December 31, 2013, the following warrants to purchase our common stock were outstanding and classified as equity:

Issuance Date
  Exercise Price   Number of
Shares
  Exercisable Date   Expiration Date

November 2011(1)

  $ 2.32     461,382   November 2011   November 2021

August 2011(1)

  $ 3.98     537,893   August 2011   August 2021

September 2009

  $ 9.00     150,000   September 2009   September 2014

April 2005

  $ 3.75     470,000   April 2005   April 2015
                   

 

          1,619,275        
                   
                   

(1)
In connection with each disbursement under the loan agreement with CIRM, we were obligated to issue to CIRM a warrant to purchase Geron common stock. Each of the warrants and the underlying common stock were unregistered. We have no further obligations to issue any additional warrants to CIRM.
Schedule of aggregate option and award activity

Aggregate option and award activity for the 2002 Plan, 2011 Plan, 1996 Directors Plan and 2006 Directors Plan is as follows:

 
   
  Outstanding Options  
 
  Shares
Available
For Grant
  Number of
Shares
  Weighted Average
Exercise Price
Per Share
  Weighted Average
Remaining
Contractual Life
(In years)
  Aggregate
Intrinsic
Value
(In thousands)
 

Balance at December 31, 2012

    13,557,771     17,811,506   $ 4.05         $ 2  

Options granted

    (6,366,000 )   6,366,000   $ 1.57              

Awards granted

    (66,853 )     $              

Options exercised

        (1,960,245 ) $ 3.35              

Options canceled/forfeited

    6,641,045     (6,641,045 ) $ 4.25              

Awards canceled/forfeited

    2,441,287       $              
                             

Balance at December 31, 2013

    16,207,250     15,576,216   $ 3.04     6.83   $ 33,798  
                             
                             

Options exercisable at December 31, 2013

          8,144,040   $ 4.26     5.05   $ 11,194  
                               
                               

Options fully vested and expected to vest at December 31, 2013

          15,122,068   $ 3.08     6.77   $ 32,402  
                               
                               
Schedule of information about stock options outstanding by exercise price range

 Information about stock options outstanding as of December 31, 2013 is as follows:

 
  Options Outstanding  
Exercise Price Range
  Number of
Shares
  Weighted Average
Exercise Price
Per Share
  Weighted Average
Remaining
Contractual Life
(In years)
 

$1.10 - $1.50

    4,627,834   $ 1.42     8.57  

$1.51 - $1.70

    4,217,041   $ 1.54     9.04  

$1.71 - $6.39

    4,067,162   $ 3.78     6.16  

$6.40 - $9.32

    2,664,179   $ 7.08     1.35  
                   

$1.10 - $9.32

    15,576,216   $ 3.04     6.83  
                   
Schedule of aggregate restricted stock activity

Aggregate restricted stock activity for the 2002 Plan, 2011 Plan and 2006 Directors Plan is as follows:

 
  Number of
Shares
  Weighted
Average
Grant Date
Fair Value
Per Share
  Weighted Average
Remaining
Contractual Term
(In years)
 

Non-vested restricted stock at December 31, 2012

    2,917,962   $ 4.08     0.90  

Granted

    66,853   $ 2.41        

Vested

    (134,091 ) $ 3.77        

Canceled/forfeited

    (2,441,287 ) $ 3.92        
                   

Non-vested restricted stock at December 31, 2013(1)

    409,437   $ 4.84     0.82  
                   
                   

(1)
Includes 139,000 performance-based restricted stock awards that have not achieved certain strategic goals.
Summary of allocation of stock-based compensation expense related to share-based payment awards

The following table summarizes the stock-based compensation expense related to stock options, restricted stock awards and employee stock purchases for the years ended December 31, 2013, 2012 and 2011 which was allocated as follows:

 
  Year Ended December 31,  
 
  2013   2012   2011  
 
  (In thousands)
 

Research and development

  $ 1,741   $ 2,336   $ 5,799  

Restructuring charges

    28     107     174  

General and administrative

    2,666     2,868     9,276  
               

Stock-based compensation expense included in operating expenses

  $ 4,435   $ 5,311   $ 15,249  
               
Schedule of assumptions used to estimate the fair value of stock options granted

The fair value of stock options granted in 2013, 2012 and 2011 has been estimated at the date of grant using the Black Scholes option-pricing model with the following assumptions:

 
  2013   2012   2011

Dividend yield

  0%   0%   0%

Expected volatility range

  0.742 to 0.792   0.631 to 0.740   0.629 to 0.660

Risk-free interest rate range

  0.80% to 1.97%   0.81% to 1.25%   0.88% to 2.37%

Expected term

  6 yrs   6 yrs   5 yrs
Schedule of assumptions used to estimate the fair value of employee stock purchases under the Purchase Plan

The fair value of employee stock purchases in 2013, 2012 and 2011 under the Purchase Plan has been estimated using the Black Scholes option-pricing model with the following assumptions:

 
  2013   2012   2011

Dividend yield

  0%   0%   0%

Expected volatility range

  0.506 to 1.391   0.458 to 0.774   0.278 to 0.584

Risk-free interest rate range

  0.09% to 0.21%   0.06% to 0.21%   0.10% to 0.32%

Expected term range

  6 mos to 12 mos   6 mos to 12 mos   6 mos to 12 mos
Schedule of common stock reserved for future issuance

Common stock reserved for future issuance as of December 31, 2013 is as follows:

Outstanding stock options

    15,576,216  

Options and awards available for grant

    16,207,250  

Employee stock purchase plan

    263,404  

Warrants outstanding

    1,619,275  
       

Total

    33,666,145